Robert G Micheletti, MD

faculty photo
Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
Attending Physician, Hospital of the University of Pennsylvania
Active Medical Staff, Presbyterian Medical Center
Active Medical Staff, Pennsylvania Hospital
Chief of Hospital Dermatology, Department of Dermatology, University of Pennsylvania
Chief of Dermatology, Pennsylvania Hospital
Medical Director for Dermatology Clinic, Pennsylvania Hospital
Department: Dermatology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
7th Floor, South Tower, Room 724
Philadelphia, PA 19104-4283
Office: 215-662-2737
Education:
BA
Stanford University , 2004.
MD
Duke University School of Medicine, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Wang LL, Noe MH, Micheletti RG: Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. JAMA Dermatol Aug 2022 Notes: Epub ahead of print.

Micheletti RG: Treatment of cutaneous vasculitis. Front Med (Lausanne) 18(9): 1059612, Nov 2022.

Bhattacharya S, Basu S, Sheng E, Murphy CM, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele KT, Forrestel AK, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH: Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. J Clin Invest Page: e162137, Nov 2022 Notes: Online ahead of print.

Micheletti RG: Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management. Am J Clin Dermatol Oct 2022 Notes: Online ahead of print.

Noe MH, Micheletti RG: Systemic Interventions for Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Summary of a Cochrane Review. JAMA Dermatol Oct 2022 Notes: Online ahead of print.

Jane J Han, Andrew Creadore, Lucia Seminario-Vidal, Robert Micheletti, Megan H Noe, Arash Mostaghimi: Medical management of Stevens-Johnson syndrome/toxic epidermal necrolysis among North American dermatologists. J Am Acad Dermatol 87((2)): 429-431, Aug 2022.

Midgette B, Strunk A, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen S, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti R, Miller AP, Moseng D, Naik H, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis C, Garg A. : Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol Jul 2022 Notes: Epub ahead of print.

Coromilas AJ, Micheletti RG: A novel combination ("CHAP") regimen for management of livedoid vasculopathy in 12 patients. J Am Acad Dermatol Jul 2022 Notes: Epub ahead of print.

Rick J, Strowd L, Pasieka HB, Saardi K, Micheletti R, Zhao M, Kroshinsky D, Shinohara MM, Ortega-Loayza AG.: Calciphylaxis: Part I. Diagnosis and pathology. J Am Acad Dermatol 86(5): 973-982, May 2022.

Rick J, Rrapi R, Chand S, Shinohara MM, Strowd L, Pasieka HB, Micheletti R, Kroshinsky D, Ortega-Loayza AG.: Calciphylaxis: Treatment and outlook-CME part II. J Am Acad Dermatol 86(5): 985-992, May 2022.

back to top
Last updated: 01/26/2023
The Trustees of the University of Pennsylvania